Microsoft said it doesn't comment on rumors or speculation after Cheddar News asked for a comment about a report that the tech giant was in talks for a $10 billion investment in OpenAi.

Share:
More In Business
Biogen Lowers Full-Year Profit Forecast
Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Load More